You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

US clears sale of DNA sequencer

China firm’s bid to buy company is controversial

NEW YORK — The federal government has given national security clearance to the controversial purchase of an American DNA sequencing company by a Chinese firm.

BGI-Shenzhen said over the weekend that its acquisition of Complete Genomics, of Mountain View, Calif., had been cleared by the Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of US companies.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week